{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:10:26Z","timestamp":1790493026983,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004426","name":"Atlantic Philanthropies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004426","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Merchant Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12916-018-1173-9","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T08:09:17Z","timestamp":1538640557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-na\u00efve volunteers: a pilot study"],"prefix":"10.1186","volume":"16","author":[{"given":"Danielle I.","family":"Stanisic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Coghill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letitia","family":"Gore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue Q.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"El-Deeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid B.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Willemsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Lata","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Fong","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Gerrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,8]]},"reference":[{"key":"1173_CR1","doi-asserted-by":"publisher","DOI":"10.30875\/1cee73f9-en","volume-title":"World malaria report 2015","author":"World Health Organisation","year":"2015","unstructured":"World Health Organisation. World malaria report 2015. In: World Health Organisation, editor. ; 2015."},{"issue":"23","key":"1173_CR2","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1016\/j.vaccine.2009.03.014","volume":"27","author":"I Sagara","year":"2009","unstructured":"Sagara I, Dicko A, Ellis RD, Fay MP, Diawara SI, Assadou MH, Sissoko MS, Kone M, Diallo AI, Saye R, et al. A randomized controlled phase 2 trial of the blood stage AMA1-C1\/Alhydrogel malaria vaccine in children in Mali. Vaccine. 2009;27(23):3090\u20138.","journal-title":"Vaccine"},{"issue":"3","key":"1173_CR3","doi-asserted-by":"publisher","first-page":"e4708","DOI":"10.1371\/journal.pone.0004708","volume":"4","author":"BR Ogutu","year":"2009","unstructured":"Ogutu BR, Apollo OJ, McKinney D, Okoth W, Siangla J, Dubovsky F, Tucker K, Waitumbi JN, Diggs C, Wittes J, et al. Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya. PLoS One. 2009;4(3):e4708.","journal-title":"PLoS One"},{"issue":"11","key":"1173_CR4","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1056\/NEJMc1100670","volume":"365","author":"SB Sirima","year":"2011","unstructured":"Sirima SB, Cousens S, Druilhe P. Protection against malaria by MSP3 candidate vaccine. N Engl J Med. 2011;365(11):1062\u20134.","journal-title":"N Engl J Med"},{"issue":"12","key":"1173_CR5","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMoa1207564","volume":"368","author":"A Olotu","year":"2013","unstructured":"Olotu A, Fegan G, Wambua J, Nyangweso G, Awuondo KO, Leach A, Lievens M, Leboulleux D, Njuguna P, Peshu N, et al. Four-year efficacy of RTS, S\/AS01E and its interaction with malaria exposure. N Engl J Med. 2013;368(12):1111\u201320.","journal-title":"N Engl J Med"},{"issue":"6152","key":"1173_CR6","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1126\/science.1241800","volume":"341","author":"RA Seder","year":"2013","unstructured":"Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, Holman LA, James ER, Billingsley PF, Gunasekera A, et al. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science. 2013;341(6152):1359\u201365.","journal-title":"Science"},{"issue":"6","key":"1173_CR7","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nm.4110","volume":"22","author":"AS Ishizuka","year":"2016","unstructured":"Ishizuka AS, Lyke KE, DeZure A, Berry AA, Richie TL, Mendoza FH, Enama ME, Gordon IJ, Chang LJ, Sarwar UN, et al. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nat Med. 2016;22(6):614\u201323.","journal-title":"Nat Med"},{"issue":"5","key":"1173_CR8","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1473-3099(17)30104-4","volume":"17","author":"MS Sissoko","year":"2017","unstructured":"Sissoko MS, Healy SA, Katile A, Omaswa F, Zaidi I, Gabriel EE, Kamate B, Samake Y, Guindo MA, Dolo A, et al. Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial. Lancet Infect Dis. 2017;17(5):498\u2013509.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"1173_CR9","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1073\/pnas.1615324114","volume":"114","author":"KE Lyke","year":"2017","unstructured":"Lyke KE, Ishizuka AS, Berry AA, Chakravarty S, DeZure A, Enama ME, James ER, Billingsley PF, Gunasekera A, Manoj A, et al. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. Proc Natl Acad Sci U S A. 2017;114(10):2711\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1173_CR10","doi-asserted-by":"publisher","first-page":"e89154","DOI":"10.1172\/jci.insight.89154","volume":"2","author":"JE Epstein","year":"2017","unstructured":"Epstein JE, Paolino KM, Richie TL, Sedegah M, Singer A, Ruben AJ, Chakravarty S, Stafford A, Ruck RC, Eappen AG, et al. Protection against Plasmodium falciparum malaria by PfSPZ Vaccine. JCI Insight. 2017;2(1):e89154.","journal-title":"JCI Insight"},{"issue":"7642","key":"1173_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature21060","volume":"542","author":"B Mordmuller","year":"2017","unstructured":"Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka AS, Lalremruata A, Gmeiner M, Campo JJ, Esen M, Ruben AJ, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542(7642):445\u20139.","journal-title":"Nature"},{"key":"1173_CR12","doi-asserted-by":"crossref","unstructured":"Stanisic DI, McCarthy JS, Good MF. Controlled human malaria infection: applications, advances, and challenges. Infect Immun. 2018;86(1):e00479\u20131.","DOI":"10.1128\/IAI.00479-17"},{"issue":"4","key":"1173_CR13","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.1992.03490040092031","volume":"268","author":"SC Austin","year":"1992","unstructured":"Austin SC, Stolley PD, Lasky T. The history of malariotherapy for neurosyphilis. Modern parallels. JAMA. 1992;268(4):516\u20139.","journal-title":"JAMA"},{"key":"1173_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/B978-0-12-407826-0.00006-0","volume":"81","author":"G Snounou","year":"2013","unstructured":"Snounou G, Perignon JL. Malariotherapy--insanity at the service of malariology. Adv Parasitol. 2013;81:223\u201355.","journal-title":"Adv Parasitol"},{"issue":"52","key":"1173_CR15","doi-asserted-by":"publisher","first-page":"7469","DOI":"10.1016\/j.vaccine.2015.09.057","volume":"33","author":"DI Stanisic","year":"2015","unstructured":"Stanisic DI, Good MF. Whole organism blood stage vaccines against malaria. Vaccine. 2015;33(52):7469\u201375.","journal-title":"Vaccine"},{"issue":"38","key":"1173_CR16","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1016\/j.vaccine.2008.07.017","volume":"26","author":"LA Purcell","year":"2008","unstructured":"Purcell LA, Wong KA, Yanow SK, Lee M, Spithill TW, Rodriguez A. Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge. Vaccine. 2008;26(38):4880\u20134.","journal-title":"Vaccine"},{"issue":"3","key":"1173_CR17","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1128\/IAI.01399-07","volume":"76","author":"LA Purcell","year":"2008","unstructured":"Purcell LA, Yanow SK, Lee M, Spithill TW, Rodriguez A. Chemical attenuation of Plasmodium berghei sporozoites induces sterile immunity in mice. Infect Immun. 2008;76(3):1193\u20139.","journal-title":"Infect Immun"},{"key":"1173_CR18","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1172\/JCI66634","volume":"123","author":"MF Good","year":"2013","unstructured":"Good MF, Reiman JM, Rodriguez IB, Ito K, Yanow SK, El-Deeb IM, Batzloff MR, Stanisic DI, Engwerda C, Spithill T, et al. Cross-species malaria immunity induced by chemically attenuated parasites. J Clin Invest. 2013;123:3353\u201362.","journal-title":"J Clin Invest"},{"issue":"8","key":"1173_CR19","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1128\/IAI.00157-16","volume":"84","author":"AI Raja","year":"2016","unstructured":"Raja AI, Cai Y, Reiman JM, Groves P, Chakravarty S, McPhun V, Doolan DL, Cockburn I, Hoffman SL, Stanisic DI, et al. Chemically attenuated blood-stage Plasmodium yoelii parasites induce long-lived and strain-transcending protection. Infect Immun. 2016;84(8):2274\u201388.","journal-title":"Infect Immun"},{"issue":"4","key":"1173_CR20","doi-asserted-by":"publisher","first-page":"e1015","DOI":"10.1002\/cti2.1015","volume":"7","author":"JM Reiman","year":"2018","unstructured":"Reiman JM, Kumar S, Rodriguez IB, Gnidehou S, Ito K, Stanisic DI, Lee M, McPhun V, Majam V, Willemsen NM, et al. Induction of immunity following vaccination with a chemically attenuated malaria vaccine correlates with persistent antigenic stimulation. Clin Transl Immunol. 2018;7(4):e1015.","journal-title":"Clin Transl Immunol"},{"issue":"11","key":"1173_CR21","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1021\/jm050179u","volume":"48","author":"A Sato","year":"2005","unstructured":"Sato A, McNulty L, Cox K, Kim S, Scott A, Daniell K, Summerville K, Price C, Hudson S, Kiakos K, et al. A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065. J Med Chem. 2005;48(11):3903\u201318.","journal-title":"J Med Chem"},{"issue":"9","key":"1173_CR22","doi-asserted-by":"publisher","first-page":"5178","DOI":"10.1128\/IAI.71.9.5178-5187.2003","volume":"71","author":"Z Su","year":"2003","unstructured":"Su Z, Tam MF, Jankovic D, Stevenson MM. Vaccination with novel immunostimulatory adjuvants against blood-stage malaria in mice. Infect Immun. 2003;71(9):5178\u201387.","journal-title":"Infect Immun"},{"issue":"8","key":"1173_CR23","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1084\/jem.20151976","volume":"213","author":"C Demarta-Gatsi","year":"2016","unstructured":"Demarta-Gatsi C, Smith L, Thiberge S, Peronet R, Commere PH, Matondo M, Apetoh L, Bruhns P, Menard R, Mecheri S. Protection against malaria in mice is induced by blood stage-arresting histamine-releasing factor (HRF)-deficient parasites. J Exp Med. 2016;213(8):1419\u201328.","journal-title":"J Exp Med"},{"issue":"7","key":"1173_CR24","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/j.1462-5822.2010.01441.x","volume":"12","author":"AS Aly","year":"2010","unstructured":"Aly AS, Downie MJ, Mamoun CB, Kappe SH. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice. Cell Microbiol. 2010;12(7):930\u20138.","journal-title":"Cell Microbiol"},{"issue":"11","key":"1173_CR25","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1086\/592971","volume":"47","author":"MC D'Ombrain","year":"2008","unstructured":"D'Ombrain MC, Robinson LJ, Stanisic DI, Taraika J, Bernard N, Michon P, Mueller I, Schofield L. Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children. Clin Infect Dis. 2008;47(11):1380\u20137.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1173_CR26","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1128\/IAI.00211-09","volume":"77","author":"L Robinson","year":"2009","unstructured":"Robinson L, D'Ombrain M, Stanisic D, Taraika J, Bernard N, Richards J, Beeson J, Tavul L, Michon P, Mueller I, et al. Cellular tumour necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea. Infect Immun. 2009;77(7):3033\u201343.","journal-title":"Infect Immun"},{"issue":"1","key":"1173_CR27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1086\/648596","volume":"201","author":"MB McCall","year":"2010","unstructured":"McCall MB, Hopman J, Daou M, Maiga B, Dara V, Ploemen I, Nganou-Makamdop K, Niangaly A, Tolo Y, Arama C, et al. Early interferon-gamma response against Plasmodium falciparum correlates with interethnic differences in susceptibility to parasitemia between sympatric Fulani and Dogon in Mali. J Infect Dis. 2010;201(1):142\u201352.","journal-title":"J Infect Dis"},{"issue":"4","key":"1173_CR28","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1086\/314689","volume":"179","author":"AJ Luty","year":"1999","unstructured":"Luty AJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B, Matousek P, Herbich K, Schmid D, Migot-Nabias F, et al. Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis. 1999;179(4):980\u20138.","journal-title":"J Infect Dis"},{"issue":"9333","key":"1173_CR29","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S0140-6736(02)09784-2","volume":"360","author":"DJ Pombo","year":"2002","unstructured":"Pombo DJ, Lawrence G, Hirunpetcharat C, Rzepczyk C, Bryden M, Cloonan N, Anderson K, Mahakunkijcharoen Y, Martin LB, Wilson D, et al. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet. 2002;360(9333):610\u20137.","journal-title":"Lancet"},{"issue":"9","key":"1173_CR30","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ijpara.2016.05.002","volume":"46","author":"SL De","year":"2016","unstructured":"De SL, Stanisic DI, van Breda K, Bellete B, Harris I, McCallum F, Edstein MD, Good MF. Persistence and immunogenicity of chemically attenuated blood stage Plasmodium falciparum in Aotus monkeys. Int J Parasitol. 2016;46(9):581\u201391.","journal-title":"Int J Parasitol"},{"key":"1173_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12936-015-0663-x","volume":"14","author":"DI Stanisic","year":"2015","unstructured":"Stanisic DI, Liu XQ, De SL, Batzloff MR, Forbes T, Davis CB, Sekuloski S, Chavchich M, Chung W, Trenholme K, et al. Development of cultured Plasmodium falciparum blood-stage malaria cell banks for early phase in vivo clinical trial assessment of anti-malaria drugs and vaccines. Malar J. 2015;14:143.","journal-title":"Malar J"},{"issue":"9","key":"1173_CR32","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1128\/IAI.00414-16","volume":"84","author":"DI Stanisic","year":"2016","unstructured":"Stanisic DI, Gerrard J, Fink J, Griffin PM, Liu XQ, Sundac L, Sekuloski S, Rodriguez IB, Pingnet J, Yang Y, et al. Infectivity of Plasmodium falciparum in malaria-naive individuals is related to knob expression and cytoadherence of the parasite. Infect Immun. 2016;84(9):2689\u201396.","journal-title":"Infect Immun"},{"key":"1173_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1475-2875-10-48","volume":"10","author":"RJ Rockett","year":"2011","unstructured":"Rockett RJ, Tozer SJ, Peatey C, Bialasiewicz S, Whiley DM, Nissen MD, Trenholme K, Mc Carthy JS, Sloots TP. A real-time, quantitative PCR method using hydrolysis probes for the monitoring of Plasmodium falciparum load in experimentally infected human volunteers. Malar J. 2011;10:48.","journal-title":"Malar J"},{"issue":"1","key":"1173_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1475-2875-7-139","volume":"7","author":"David J Padley","year":"2008","unstructured":"Padley DJ, Heath AB, Sutherland C, Chiodini PL, Baylis SA, Collaborative Study G: Establishment of the 1st World Health Organization International Standard for Plasmodium falciparum DNA for nucleic acid amplification technique (NAT)-based assays. Malar J 2008, 7:139.","journal-title":"Malaria Journal"},{"key":"1173_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/1475-2875-12-221","volume":"12","author":"JF Mosha","year":"2013","unstructured":"Mosha JF, Sturrock HJ, Greenhouse B, Greenwood B, Sutherland CJ, Gadalla N, Atwal S, Drakeley C, Kibiki G, Bousema T, et al. Epidemiology of subpatent Plasmodium falciparum infection: implications for detection of hotspots with imperfect diagnostics. Malar J. 2013;12:221.","journal-title":"Malar J"},{"issue":"9","key":"1173_CR36","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/intimm\/4.9.985","volume":"4","author":"J Currier","year":"1992","unstructured":"Currier J, Sattabongkot J, Good MF. \u2018Natural\u2019 T cells responsive to malaria: evidence implicating immunological cross-reactivity in the maintenance of TCR alpha beta+ malaria-specific responses from non-exposed donors. Int Immunol. 1992;4(9):985\u201394.","journal-title":"Int Immunol"},{"issue":"5","key":"1173_CR37","doi-asserted-by":"publisher","first-page":"532","DOI":"10.4269\/ajtmh.1995.53.532","volume":"53","author":"PG Kremsner","year":"1995","unstructured":"Kremsner PG, Winkler S, Brandts C, Wildling E, Jenne L, Graninger W, Prada J, Bienzle U, Juillard P, Grau GE. Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production. Am J Trop Med Hyg. 1995;53(5):532\u20138.","journal-title":"Am J Trop Med Hyg"},{"issue":"24","key":"1173_CR38","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1056\/NEJM198906153202404","volume":"320","author":"GE Grau","year":"1989","unstructured":"Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, Lambert PH. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med. 1989;320(24):1586\u201391.","journal-title":"N Engl J Med"},{"issue":"2","key":"1173_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0002-9343(89)80688-6","volume":"87","author":"P Kern","year":"1989","unstructured":"Kern P, Hemmer CJ, Van Damme J, Gruss HJ, Dietrich M. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med. 1989;87(2):139\u201343.","journal-title":"Am J Med"},{"issue":"4","key":"1173_CR40","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1086\/315016","volume":"180","author":"NP Day","year":"1999","unstructured":"Day NP, Hien TT, Schollaardt T, Loc PP, Chuong LV, Chau TT, Mai NT, Phu NH, Sinh DX, White NJ, et al. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis. 1999;180(4):1288\u201397.","journal-title":"J Infect Dis"},{"issue":"6","key":"1173_CR41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ijpara.2012.03.010","volume":"42","author":"AP Freitas do Rosario","year":"2012","unstructured":"Freitas do Rosario AP, Langhorne J. T cell-derived IL-10 and its impact on the regulation of host responses during malaria. Int J Parasitol. 2012;42(6):549\u201355.","journal-title":"Int J Parasitol"},{"issue":"12","key":"1173_CR42","doi-asserted-by":"publisher","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","volume":"182","author":"T Lindenstrom","year":"2009","unstructured":"Lindenstrom T, Agger EM, Korsholm KS, Darrah PA, Aagaard C, Seder RA, Rosenkrands I, Andersen P. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J Immunol. 2009;182(12):8047\u201355.","journal-title":"J Immunol"},{"issue":"7","key":"1173_CR43","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","volume":"13","author":"PA Darrah","year":"2007","unstructured":"Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ, Hoff ST, Andersen P, Reed SG, Morris SL, et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med. 2007;13(7):843\u201350.","journal-title":"Nat Med"},{"issue":"5","key":"1173_CR44","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1056\/NEJMoa0805832","volume":"361","author":"M Roestenberg","year":"2009","unstructured":"Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, van Gemert GJ, van de Vegte-Bolmer M, van Schaijk B, Teelen K, Arens T, et al. Protection against a malaria challenge by sporozoite inoculation. N Engl J Med. 2009;361(5):468\u201377.","journal-title":"N Engl J Med"},{"issue":"10","key":"1173_CR45","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1128\/AAC.49.10.4421-4422.2005","volume":"49","author":"MD Edstein","year":"2005","unstructured":"Edstein MD, Kotecka BM, Anderson KL, Pombo DJ, Kyle DE, Rieckmann KH, Good MF. Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration. Antimicrob Agents Chemother. 2005;49(10):4421\u20132.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-018-1173-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-018-1173-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-018-1173-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T19:07:36Z","timestamp":1570475256000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-018-1173-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,8]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1173"],"URL":"https:\/\/doi.org\/10.1186\/s12916-018-1173-9","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,8]]},"assertion":[{"value":"25 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Griffith University Human Research Ethics Committee (GLY\/01\/14\/HREC). The study was conducted in accordance with the principles of the Declaration of Helsinki and the standards of Good Clinical Practice as defined by the International Conference on Harmonisation. Written informed consent was obtained from all participants prior to commencement of the study. The use of human blood products for culture of <i>P. falciparum<\/i> and <i>P. knowlesi<\/i> was approved by the Griffith University Human Research Ethics Committee (BDD\/02\/14\/HREC). As part of standard Australian Red Cross Blood Service practice, donors consent each time they donate blood or blood products for the use of their donation for research purposes.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to publish data from the study was obtained from all participants prior to commencement of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DS, XL, IED, IR, JP, NW, SD, MH and MG declare competing interests. At the time of this study, they were employees of Griffith University, which co-owns a patent family \u201cBlood-Stage Malaria Vaccine\u201d. This patent family is related to the work described in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"184"}}